B L Hillcoat. Show Affiliations »
Abstract
Mesh： See more » AdultAustraliaChildGaucher Disease/therapyGlucosylceramidase/therapeutic useHumansOrphan Drug Production/legislation & jurisprudencePolicy MakingRabies/drug therapyRabies Vaccines/administration & dosageRecombinant Proteins/therapeutic useUnited StatesUnited States Food and Drug Administration
Substances： See more » Rabies VaccinesRecombinant ProteinsGlucosylceramidaseimiglucerase
Year: 1998 PMID： 9700338 DOI： 10.5694/j.1326-5377.1998.tb140184.x
Source DB: PubMed Journal: Med J Aust ISSN： 0025-729X Impact factor: 7.738